LIMERICK BIOPHARMA INC — Form D/A
LIMERICK BIOPHARMA INC of So. San Francisco, CA, a company, filed a Form D amendment with the SEC on 2009-08-20. The offering totals $15.4M, of which $15.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2009-08-20
- Form: D/A
- Accession: 0001104659-09-050810
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $15.4M
- Amount sold: $15.4M
- Investors: 17
- Date of first sale: 2009-07-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-88136
Issuer
- Name: LIMERICK BIOPHARMA INC
- CIK: 0001358877
- Entity type: Corporation
- Jurisdiction: CALIFORNIA
- Incorporated: 2004
- Address: 601 Gateway Boulevard, Suite 700, So. San Francisco, CA, 94080
- Phone: 650-742-0110
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Stephen Dow | Director | Needham, MA |
| Scott Minick | Director | Sunnyvale, CA |
| Chad Waite | Director | SEATTLE, WA |
| Kristina Burow | Director | San Diego, CA |
| Corey Goodman | Director | Cambridge, MA |
| Steve Dow | Director | Seattle, WA |
| Wendye Robbins | Director | SOUTH SAN FRANCISCO, CA |
| Wendye Robbins | Executive Officer | SOUTH SAN FRANCISCO, CA |
| Corey S Goodman | Director | Austin, TX |
| Ving Lee | Executive Officer | South San Francisco, CA |
| Asha Rajagopal | Executive Officer | South San Francisco, CA |
| Stephen M Dow | Director | So. San Francisco, CA |
Other filings by this issuer (6)
More